{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:53:39Z","timestamp":1761893619645},"reference-count":25,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2002,1,4]],"date-time":"2002-01-04T00:00:00Z","timestamp":1010102400000},"content-version":"vor","delay-in-days":1130,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[1998,12]]},"abstract":"<jats:p>In an attempt to define the clinical utility of immunoglobulin heavy chain (IgH) gene rearrangement identification for tumour cell detection in multiple myeloma, we investigated 36 consecutive newly diagnosed patients intended for high\u2010dose chemotherapy in a study protocol. After identification of the IgH rearrangement, an allele specific oligonucleotide (ASO) was constructed and used in a semiquantative PCR for minimal residual disease (MRD) evaluation. The myeloma\u2010specific IgH gene rearrangement could be identified and an ASO primer constructed in 24 (67%) of the patients. All of these patients underwent transplantation; 22 were autologous, of whom three had PCR\u2010negative stem cell harvests, and two were allogeneic. 10 patients achieved a clinical complete response (CR) and five were PCR negative in sequential bone marrow analyses. In patients not achieving CR, PCR negativity was occasionally found, but in general the PCR results reflected the clinical status of the patients. No consistent relationship between the bone marrow MRD status and the clinical course was found, and early relapses occurred also in PCR\u2010negative patients.<\/jats:p>","DOI":"10.1046\/j.1365-2141.1998.01075.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:07:45Z","timestamp":1047362865000},"page":"1145-1151","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Clinical utility of immunoglobulin heavy chain gene rearrangement identification for tumour cell detection in multiple myeloma"],"prefix":"10.1111","volume":"103","author":[{"given":"Agneta","family":"Swedin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stig","family":"Lenhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tor","family":"Olofsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britt","family":"Thuresson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Westin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,1,4]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199402173300709"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198312293092601"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199607113350204"},{"key":"e_1_2_6_5_2","first-page":"71","article-title":"Bone marrow transplantation in multiple myeloma","volume":"7","author":"Barlogie B.","year":"1991","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V78.11.3021.3021"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400773"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb04985.x"},{"key":"e_1_2_6_9_2","first-page":"651","article-title":"Minimal residual disease after bone marrow transplantation for multiple myeloma: evidence for cure in long\u2010term survivors","volume":"12","author":"Bird J.M.","year":"1993","journal-title":"Bone Marrow Transplantation"},{"issue":"1","key":"e_1_2_6_10_2","article-title":"2522 autotransplants in multiple myeloma: a registry study from the European Group for Blood and Marrow Transplantation (EBMT)","volume":"90","author":"Bj\u00f6rkstrand B.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_11_2","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1182\/blood.V85.6.1596.bloodjournal8561596","article-title":"High\u2010dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting","volume":"85","author":"Corradini P.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb08570.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199110313251802"},{"key":"e_1_2_6_14_2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1182\/blood.V86.1.381.bloodjournal861381","article-title":"Purified CD34+ Lin\u2212 Thy+ stem cells do not contain clonal myeloma cells","volume":"86","author":"Gazitt Y.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00574.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.2.334"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb02564.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.1792996.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1182\/blood.V88.6.2228.bloodjournal8862228","article-title":"Eradication of polymerase chain reaction\u2010detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation","volume":"88","author":"Provan D.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_20_2","first-page":"31","article-title":"A possible mechanism of inability of immunoglobulin heavy\u2010chain production in Bence\u2010Jones type myeloma cells","volume":"59","author":"Sakai A.","year":"1993","journal-title":"International Journal of Hematology"},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/blood.V89.5.1824","article-title":"CD34+ cells in the blood of patients with multiple myeloma express CD19 and IgH mRNA and have patient\u2010specific IgH VDJ gene rearrangements","volume":"89","author":"Szczepek A.J.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-2038.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1182\/blood.V84.10.3283.3283","article-title":"The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma","volume":"84","author":"Vescio R.A.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199509112199"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb08378.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1182\/blood.V88.9.3314.bloodjournal8893314","article-title":"Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangements in non\u2010Hodgkin's lymphoma is associated with decreased relapse after autologous bone marrow transplantation","volume":"88","author":"Zwicky C.S.","year":"1996","journal-title":"Blood"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.1998.01075.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.1998.01075.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.1998.01075.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T04:15:28Z","timestamp":1698466528000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.1998.01075.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998,12]]}},"alternative-id":["10.1046\/j.1365-2141.1998.01075.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.1998.01075.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,12]]},"assertion":[{"value":"2002-01-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}